Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genes Modulating the Severity of Aortic Aneurysms (MSF1-TGFBR2)

NCT05146375 is registered in ClinicalTrials.gov with French Cardiology Society as lead sponsor.

NCT NCT05146375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05146375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genes Modulating the Severity of Aortic Aneurysms (MSF1-TGFBR2)
Lead sponsor
French Cardiology Society
Phase
Observational
Overall status
Completed
Start date
November 24, 2022
Completion date
November 30, 2025
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thoracic aortic aneurysm